View Older Stories View More Recent Stories

Jun 14, 2022 02:01AM PureTech Meets Milestone of Achieving Oral Bioavailability of Allopregnanolone in Healthy Adults Dosed with LYT-300
Jun 14, 2022 02:00AM PureTech Reports Results from Phase 2 Study of LYT-100-COV in Post-Acute “Long” COVID with Respiratory Complications
Jun 6, 2022 07:05AM PureTech Health Plc (PRTC) Announces Akili Appoints Matt Franklin as President and COO
Jun 6, 2022 07:05AM PureTech Founded Entity Akili Announces Veteran Life Sciences Executive Matt Franklin in Newly Created Role of President and Chief Operating Officer
Jun 1, 2022 07:00AM PureTech to Present at the Jefferies Healthcare Conference
May 26, 2022 07:05AM PureTech Health's (PRTC) Akili Integrates Prescription Video Game Treatment with the Virtual World Through Partnership with Roblox
May 26, 2022 07:05AM PureTech Founded Entity Akili Integrates First-of-its-Kind Prescription Video Game Treatment with the Virtual World Through Partnership with Roblox
May 24, 2022 05:50AM PureTech's (PRTC) Vedanta Biosciences Presented Data from Multiple Studies
May 24, 2022 03:05AM PureTech Founded Entity Vedanta Biosciences Presents Data from Multiple Studies at Digestive Disease Week 2022 Annual Meeting
May 17, 2022 07:00AM PureTech to Present at the UBS Global Healthcare Conference
May 16, 2022 09:30AM PureTech (PRTC) Presents Additional Phase 1 Data for LYT-100
May 16, 2022 09:30AM PureTech Presents Additional Phase 1 Data for LYT-100 at American Thoracic Society 2022
May 9, 2022 02:00AM PureTech Announces Share Buyback Program Update
May 5, 2022 05:46AM PureTech Health Plc (PRTC) Announces $50M Share Buyback
May 5, 2022 02:00AM PureTech Announces Share Buyback Program of up to $50 Million
May 4, 2022 06:35AM PureTech Founded Entity Gelesis Announces Clinical Data Demonstrating Weight Loss with GS200 in Adults with Prediabetes and Type 2 Diabetes Presented at the European Congress on Obesity 2022
Apr 29, 2022 06:05AM PureTech Founded Entity Gelesis Announces its Proprietary Superabsorbent Hydrogel Induced Beneficial Changes to the Gut Microbiota and Expanded Akkermansia, a Bacterial Species Associated with Gut Hea
Apr 26, 2022 02:00AM PureTech Announces Annual Results for Year Ended December 31, 2021
Apr 13, 2022 11:58AM PureTech's (PRTC) Founded Vedanta Biosciences Publishes Phase 1a/1b Results for Lead Program VE303
Apr 13, 2022 11:46AM PureTech Founded Entity Vedanta Biosciences Publishes Phase 1a/1b Results for Lead Program VE303 in Cell Host & Microbe and Highlights Planned Presentations of Phase 2 VE303 Results
Apr 12, 2022 07:06AM PureTech Health-Founded (PRTC) Akili Interactive Reports Publication of Data Demonstrating its Digital Therapeutic AKL-T03 Improves Cognitive Impairments in Adults w/ Major Depressive Disorder When Co
Apr 12, 2022 07:05AM PureTech Founded Entity Akili Announces American Journal of Psychiatry Publication of Data Demonstrating its Digital Therapeutic AKL-T03 Improves Cognitive Impairments in Adults w/ Major Depressive Di
Apr 12, 2022 05:41AM PureTech Health (PRTC) Announces Publication from Collaborators Demonstrating PureTech’s Glyph Platform Enhances Oral Absorption of Buprenorphine
Apr 12, 2022 02:00AM PureTech Announces Publication of Research from Collaborators Demonstrating PureTech’s Glyph™ Platform Enhances Oral Absorption of Buprenorphine (a Clinically-Validated Opioid Replacement Therapy)
Apr 7, 2022 02:00AM PureTech Health: Notice of Results
Mar 24, 2022 03:00AM PureTech Appoints Sharon Barber-Lui to Board of Directors & Audit Committee
Mar 17, 2022 09:06AM PureTech Health's (PRTC) Akili Appoints Jon David as Chief Product Officer
Mar 17, 2022 09:05AM PureTech Founded Entity Akili Appoints Game Industry Veteran Behind Bejeweled, Plants vs. Zombies as Chief Product Officer
Mar 16, 2022 06:36AM PureTech Health's (PRTC) Gelesis Holdings (GLS) Reports Record Preliminary National Launch Results for Plenity
Mar 16, 2022 06:35AM PureTech Founded Entity Gelesis® Releases Preliminary National Launch Results for Plenity®: Record-Breaking Levels of Prescriptions and Online Traffic
Mar 8, 2022 07:05AM PureTech Founded Entity Akili Named to Fast Company’s Annual List of the World’s 50 Most Innovative Companies for 2022
Feb 17, 2022 07:05AM PureTech Founded Entity Akili Announces PLOS ONE Publication of Clinical Study Results and EEG Data Showing Akili Digital Therapeutic EndeavorRx® Activates Systems in Brain Key to Attentional Functio
Feb 15, 2022 05:46AM Social Capital Suvretta Holdings (PRTC) Files Form S-4 for Proposed Merger with Akili Interactive
Feb 15, 2022 02:00AM PureTech Founded Entity Akili Interactive Announces Filing of Registration Statement on S-4 in Connection with its Proposed Business Combination with Social Capital Suvretta Holdings Corp. I
Feb 10, 2022 07:00AM PureTech to Present at the SVB Leerink 11th Annual Global Healthcare Conference
Jan 31, 2022 06:50AM PureTech Founded Entity Gelesis to Launch Plenity® National Media Campaign That Challenges Restrictive Dieting Norms
Jan 26, 2022 07:02AM PureTech Founded Entity Akili Interactive, a Leader in Digital Medicine, to Become Publicly Traded Through Combination with Social Capital Suvretta Holdings Corp. I
Jan 14, 2022 02:00AM PureTech Founded Entity Gelesis, the Maker of Plenity® for Weight Management, Will Debut as a Publicly Traded Company Following the Closing of its Business Combination with Capstar
Jan 7, 2022 07:00AM PureTech to Present at 40th Annual J.P. Morgan Healthcare Conference
Jan 6, 2022 02:00AM PureTech’s LYT-100 (Deupirfenidone) Achieves 50% Reduction in Healthy Older Adults Experiencing GI-Related Adverse Events Compared to Pirfenidone
Jan 5, 2022 07:05AM PureTech Founded Entity Gelesis Appoints Inogen Co-Founder and Former CFO Ali Bauerlein to Board of Directors and Audit Committee
Dec 16, 2021 05:57AM PureTech Health Plc (PRTC) Issues End of Year Report on Key Progress Across Wholly Owned Programs and Founded Entities
Dec 16, 2021 02:00AM PureTech Provides End of Year Report on Key Progress Across Wholly Owned Programs and Founded Entities
Dec 8, 2021 07:00AM PureTech Health Plc (PRTC) Reports Preclinical Proof-of-Concept Data for LYT-300
Dec 8, 2021 07:00AM PureTech Presents Preclinical Proof-of-Concept Data for LYT-300 (Oral Allopregnanolone) as Potential Treatment for Neurological and Neuropsychological Conditions
Dec 7, 2021 07:07AM PureTech Health Plc (PRTC) Advances LYT-300 nto Clinical Study for Potential Treatment of Neurological and Neuropsychological Conditions
Dec 7, 2021 07:00AM PureTech Advances Wholly-Owned Candidate LYT-300 (Oral Allopregnanolone) into Clinical Study for Potential Treatment of Neurological and Neuropsychological Conditions
Dec 1, 2021 07:10AM PureTech Founded Entity Gelesis Announces FDA-Cleared Weight Management Approach, Plenity®, Now Broadly Available and Leading Nutrition Authority Joy Bauer, MS, RDN, CDN, Joins as Chief Nutrition Off
Nov 18, 2021 07:12AM PureTech's (PRTC) Gelesis (CPSR) Announces $30M Plenity Order from Ro
Nov 18, 2021 07:10AM PureTech Founded Entity Gelesis Receives $30 Million Plenity® Order from Ro
View More Recent Stories View Older Stories